| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 09/23/2003 | US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis |
| 09/23/2003 | US6623721 Conjugates can be complexed to a radioisotope metallic element and used for diagnosing or treating receptor-positive tumors |
| 09/23/2003 | CA2127110C Carbamates and crop protection agents containing them |
| 09/18/2003 | WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003075839A2 Methods of inducing terminal differentiation |
| 09/18/2003 | WO2003075836A2 Cathepsin cysteine protease inhibitors |
| 09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
| 09/18/2003 | WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 09/18/2003 | US20030176495 HIV Integrase inhibitors |
| 09/18/2003 | CA2671976A1 Methods of inducing terminal differentiation |
| 09/17/2003 | EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/17/2003 | EP1343753A2 Antimicrobial agents |
| 09/17/2003 | CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/16/2003 | US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 09/12/2003 | WO2003074476A1 Novel arylamidine derivative or salt thereof |
| 09/12/2003 | WO2003002522A3 Peptide deformylase inhibitors |
| 09/10/2003 | EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion |
| 09/04/2003 | US20030166577 Inhibitors for the blood-clotting factor xa |
| 09/03/2003 | EP1339702A1 5-amide substituted diarylamines as mek inhibitors |
| 09/03/2003 | EP1339663A2 Naphthalene derivatives |
| 08/28/2003 | WO2003070691A1 N-hydroxycarboxamide derivative |
| 08/28/2003 | WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 08/28/2003 | CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 08/26/2003 | US6610739 Amide and ester derivatives |
| 08/26/2003 | US6610729 Hydroxamic acid derivatives and medicinal utilization thereof |
| 08/20/2003 | EP1336615A2 Metal complexes with iminohyrdoxamic acid as a ligand |
| 08/20/2003 | EP1336613A2 Metal complexes with iminohydroxamic acid as a ligand |
| 08/20/2003 | EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 08/20/2003 | EP1335718A1 6-methoxy-2-naphthylacetic acid prodrugs |
| 08/20/2003 | EP0859591B1 Use of at least one no synthase inhibitor for treating sensitive skin |
| 08/20/2003 | CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 08/20/2003 | CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors |
| 08/14/2003 | WO2003066889A2 Assay for acytyltransferase or deacetylase activity |
| 08/14/2003 | WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/14/2003 | CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/12/2003 | US6605626 Antithrombotic agents |
| 08/12/2003 | US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 08/07/2003 | US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 08/07/2003 | US20030149084 Cytostatic agents |
| 08/06/2003 | EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
| 08/06/2003 | CN1117080C Method for producing (hetero) aromatic hydroxylamines |
| 08/06/2003 | CN1117074C Benzamidoxim derivatives, intermediate productsand method for preparing and using as fungicides |
| 07/31/2003 | WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 07/31/2003 | CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/30/2003 | CN1433399A Multistage process for preparation of highly pure deferoxamine mesylate salt |
| 07/30/2003 | CN1432562A Intermediate product for preparing benzamidoxime derivative |
| 07/29/2003 | US6600057 Matrix metalloproteinase inhibitors |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/23/2003 | CN1431195A Synthesis of 5-(3-[exo-dicyclo [2,2,1] heptyl-2-ylidene oxy]-4-methoxy phenyl)-3,4,5,6-tetrahydropyrimidine-2 (1H) ketonic intermediate and its prepn. process |
| 07/23/2003 | CN1431194A Synthesis of 5-(3-[exo-dicyclo [2,2,1] heptyl-2-ylidene oxy]-4-methoxy phenyl)-3,4,5,6-tetrahydropyrimidine-2 (1H) ketonic intermediate, and its prepn. process |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/17/2003 | WO2003057664A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 07/17/2003 | WO2003048114A3 Bacterial enzyme inhibitors |
| 07/17/2003 | CA2471752A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 07/16/2003 | CN1430599A Phenylglycine derivatives |
| 07/15/2003 | US6593363 The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1). |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | US20030125389 Or pharmaceutically acceptable salts, prodrugs, or isomers thereof |
| 07/03/2003 | US20030125306 N-methyl-6-phenyl-3,5-hexadienoylhydroxamic acid as an example; gene expression inhibition; antitumor and -carcinogenic agents; blood disorders (hemoglobinopathies); genetic disorders/metabolic disorders (cystic fibrosis) |
| 07/02/2003 | CN1427721A Peptide deformylase inhibitors |
| 06/26/2003 | US20030120085 Novel benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides |
| 06/26/2003 | US20030119807 Inhibit Procollagen C-proteinase; antiscarring treatment for wounds. |
| 06/25/2003 | EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 06/19/2003 | WO2003049690A2 Hiv integrase inhibitors |
| 06/19/2003 | US20030114529 HO-NH-(C=O)-CH2-CH(-CH2-CH(CH3)2)-(C=O)-V-,V=valine or another amino acid connected with an amino acid sequence of 10 or more amino acids; useful for treating diseases caused by cartilage degradation |
| 06/19/2003 | US20030114508 Fused imidazolium derivatives |
| 06/18/2003 | EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 06/18/2003 | EP1318974A2 Resorcinol derivatives |
| 06/18/2003 | EP1318802A2 Substituted hydrazine derivatives |
| 06/18/2003 | CN1111520C Matrix metalloprotease inhibitors |
| 06/17/2003 | US6579890 Matrix metalloprotease inhibitors |
| 06/12/2003 | WO2003048114A2 Bacterial enzyme inhibitors |
| 06/11/2003 | EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 06/11/2003 | EP1317416A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 06/11/2003 | CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors |
| 06/10/2003 | US6576780 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 06/10/2003 | US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor |
| 06/10/2003 | US6576628 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis |
| 06/10/2003 | US6576596 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect |
| 06/05/2003 | US20030105280 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy -carbonyl)phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation |
| 06/04/2003 | EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient |
| 06/03/2003 | CA2115432C Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors |
| 05/28/2003 | EP1314721A1 Novel propenohydroxamic acid derivatives |
| 05/28/2003 | EP1313694A1 Process for making n-aryl-anthranilic acids and their derivatives |
| 05/27/2003 | US6569899 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient |
| 05/22/2003 | WO2003042150A1 Novel bensophenone derivatives or salts thereof |
| 05/21/2003 | EP1283711A4 Peptide deformylase inhibitors |
| 05/21/2003 | CN1419536A Process for the selective N-formylation of n-hydroxylamines |
| 05/20/2003 | US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/20/2003 | CA2110693C Amino acid derivative anticonvulsant |
| 05/14/2003 | EP1309583A2 Process for preparing discodermolide and analogues thereof |
| 05/14/2003 | EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 05/14/2003 | EP1309543A1 Preparation of fatty hydroxamate |
| 05/13/2003 | US6562613 Recombinant C-proteinase and processes, methods and uses thereof |
| 05/08/2003 | US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 05/06/2003 | US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/01/2003 | US20030083521 Such as 5-phenyl-2,4-pentadienoylhydroxamic acid; for treating cancer, hematopoiesis, and genetic metabolic disorders (cystic fibrosis and adrenoleukodystrophy) |